Annovis Bio CFO Mark Guerin departs; CEO Maria Maccecchini appointed acting CFO

Annovis Bio, Inc.

Mark Guerin left as CFO effective March 23, 2026; departure unrelated to any disagreement with the company.
CEO Maria Maccecchini will serve as Acting CFO until a permanent replacement is identified.
No financial impact disclosed; company continues operations with existing management.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.